How have COVID-19 stringency measures changed scholarly activity?

Abstract

Government restrictions to the movement of people due to the COVID-19 pandemic have resulted in a reduction in the number of registered non COVID-19 clinical trials which was in turn negatively correlated with the stringency index of a country. This could have serious consequences for the discovery of treatments that are required to reduce the global burden of disease (GBD)